Kunlatida Maneenil
Kunlatida Maneenil publishes mostly in Pulmonary and Respiratory Medicine, Oncology and Surgery, on topics such as Lung Cancer Treatments and Mutations, Cholangiocarcinoma and Gallbladder Cancer Studies and Hepatocellular Carcinoma Treatment and Prognosis.
- World rank
- #2,698,102 of 7,710,434 ranked researchers
- Rank in Thailand
- #5,534 of 23,698
- Works
- 30
- Citations
- 1.1k
- Citations per work
- 36.8
What does Kunlatida Maneenil research?
Kunlatida Maneenil's work is mostly in Medicine (71%), Economics, Econometrics and Finance (5%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences2171.1%
- Medicine2171.1%
- Everything else723.6%
- Social Sciences25.3%
- 1Pulmonary and Respiratory Medicine21% of their works
- 2Oncology16% of their works
- 3Surgery14% of their works
- 4Hepatology12% of their works
- 5Epidemiology8% of their works
- 6Economics and Econometrics5% of their works
Research topics
- Lung Cancer Treatments and Mutations
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Hepatocellular Carcinoma Treatment and Prognosis
- Lung Cancer Diagnosis and Treatment
- Liver Disease Diagnosis and Treatment
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- Economic and Financial Impacts of Cancer
Which keywords describe Kunlatida Maneenil's research?
The keywords of their largest research topics: Clinical Trials, Targeted Therapy, Prognostic Factors, ALK Inhibitors, EGFR Mutations, Hepatocellular Carcinoma, Chemotherapy and Biliary Tract Cancer.
- PD-1 and PD-L1
- NAFLD
- Genomic Profiles
- Cost of Care
- CT Screening
- Liver Cancer
- Biliary Tract Cancer
- Hepatocellular Carcinoma
- ALK Inhibitors
- Targeted Therapy
- Clinical Trials
- Prognostic Factors
- EGFR Mutations
- Chemotherapy
- Cholangiocarcinoma
- Management
- Lung Cancer
- Financial Toxicity
- Immune Checkpoint Blockade
- NASH
- Small-Cell Lung Cancer
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 21 words, with their numbers
- Clinical Trials112 topics
- Targeted Therapy112 topics
- Prognostic Factors92 topics
- ALK Inhibitors81 topic
- EGFR Mutations81 topic
- Hepatocellular Carcinoma82 topics
- Chemotherapy72 topics
- Biliary Tract Cancer61 topic
- Cholangiocarcinoma61 topic
- Liver Cancer51 topic
- Management51 topic
- CT Screening41 topic
- Lung Cancer41 topic
- Cost of Care31 topic
- Financial Toxicity31 topic
- Genomic Profiles31 topic
- Immune Checkpoint Blockade31 topic
- NAFLD31 topic
- NASH31 topic
- PD-1 and PD-L131 topic
- Small-Cell Lung Cancer31 topic
Where does Kunlatida Maneenil work?
Kunlatida Maneenil's main affiliation in the publication record is Rajavithi Hospital, Thailand.
How many publications and citations does Kunlatida Maneenil have?
OpenAlex counts 30 works and 1,105 citations for Kunlatida Maneenil, an h-index of 7, ranking #2,698,102 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Kunlatida Maneenil. Posts are plain text and can be reported.